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EVALUATION OF THE BIOAVAILABILITY AND METABOLISM OF 
VITAMIN D2 IN A MUSHROOM SUPPLEMENT COMPARED TO 
SUPPLEMENTAL VITAMIN D2 AND SUPPLEMENTAL VITAMIN D3 
JAIMEE MARIE BOGUSZ 
ABSTRACT 
 Mushrooms can produce vitamin D2 when exposed to sunlight or 
ultraviolet radiation.  The goal of this research was to determine if ingesting dried white 
button mushroom extract (Agaricus bisporus) containing vitamin D2 (Monterey 
Mushrooms, Inc., CA) was effective at increasing and maintaining vitamin D status when 
compared to supplemental vitamin D3 and supplemental vitamin D2. Seventy five healthy 
adults were enrolled in the study (25 male, 50 female, mean age 29.9 years) and were 
randomized to ingest capsules containing 2000 IU vitamin D2, 2000 IU vitamin D3, 2000 
IU mushroom vitamin D2, or a capsule containing an equivalent amount of mushroom 
powder once a day for three months during the winters of 2012 and 2013 in Boston, 
Massachusetts.  Baseline serum total 25(OH)D levels were not significantly different 
between the groups 19.6 ± 2.1 ng/mL, and 23.9 ± 2.1 ng/mL, and 23.8 ± 2.3  ng/mL, 22.2 
± 2.0 ng/mL for the supplemental vitamin D2, mushroom powder, supplemental vitamin 
D3, and mushroom vitamin D2 groups respectively. Serum 25(OH)D levels gradually 
increased and plateaued at 7 weeks and were maintained for the following 5 weeks. At 
the end of 12 weeks, the change in serum 25(OH)D concentrations was statistically 
significantly different between groups taking supplemental vitamin D2 and mushroom 
powder (p < 0.001), supplemental vitamin D3 and mushroom powder (p < 0.0001), 
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mushroom vitamin D2 and mushroom powder (p = 0.01). Serum 25(OH)D concentrations 
increased by 75 ± 20%, 11 ± 4%, 98 ± 10%, and 66 ± 19% in the supplemental vitamin 
D2, mushroom powder, supplemental vitamin D3, and mushroom vitamin D2 groups 
respectively. Serum 1,25(OH)2D concentrations in all groups did not change over the 
course of 12 weeks. Groups taking supplemental vitamin D2 or mushroom vitamin D2 had 
an increase in serum concentrations of 1,25(OH)2D2 concentrations with an equal 
decrease in 1,25(OH)2D3. These results indicate that 1,25(OH)2D concentrations are 
tightly regulated regardless of the source of vitamin D. Thus, mushroom vitamin D2 is 
effective at increasing and maintaining serum 25(OH)D and 1,25(OH)2D levels similar to 
supplemental vitamin D2 and supplemental vitamin D3. Supported by the Mushroom 
Council. 
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INTRODUCTION 
Sources of Vitamin D and Definition of Vitamin D Deficiency 
Vitamin D, also known as the sunshine vitamin, is a hormone produced 
endogenously in the skin of vertebrates, fungi, and unicellular organisms when exposed 
to ultraviolet B (UVB) radiation. The sun is the primary source of vitamin D. Ultraviolet 
B radiation, wavelengths 290 to 315 nanometers (nm), converts 7-dehydrocholesterol (7-
DHC) to previtamin D3. Previtamin D3 is thermodynamically unstable and quickly 
isomerizes to vitamin D (Holick, 1985). During exposure to sunlight, excess previtamin 
D formed is converted into inactive photoproducts such as lumisterol and tachysterol, 
thereby preventing vitamin D intoxication from the sun (Holick, 1985).  
Few foods naturally contain vitamin D. There are many forms of vitamin D, the 
two predominant being vitamin D2 and vitamin D3. Vitamin D2 is converted from 
ergosterol in fungi such as yeast and mushrooms, and vitamin D3 is produced from 
cholesterol in lanolin (Holick, 2007). Oily fish, such as salmon, sardines, and mackerel 
contain moderate amounts of vitamin D3 ranging from 250-1000 International Units (IU) 
per 3.5 ounces (Holick, 2007). Farmed salmon has been found to contain 10-25% of the 
vitamin D3 of wild caught salmon, making wild caught salmon a better source of vitamin 
D (Holick, 2007). Some cereals, milk, and orange juices are fortified with vitamin D3 and 
contain about 100 IUs per 8 ounces of fluid (Holick, 2007).  
A third source of vitamin D is prescription and over-the-counter supplements. 
Vitamin D2 is available as a prescription for 50,000 IU. This is taken once a week for 
eight weeks and every other week thereafter for life for people at risk for vitamin D 
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deficiency. This dose amounts to about 6600 IUs per day for the first eight weeks and 
3300 IUs per day once taken every other week and was found to be safe for up to 6 years 
(Pietras et al 2009). This regimen is also an effective way to treat and prevent vitamin D 
deficiency (Demetriou, Travison, and Holick, 2012). Furthermore, vitamin D3 is available 
over-the-counter at doses ranging from 400-5000 IU and is also added to many 
multivitamins, generally at a dose of 400-1000 IU (Holick, 2007).  
Vitamin D status is determined by measuring serum 25-hydroxyvitamin D 
(25(OH)D) concentrations. Levels less than 19 nanograms per milliliter (ng/mL) are 
considered deficient, between 20-29 ng/mL insufficient, and levels 30 ng/mL and above 
are sufficient (Holick et al 2011). Comparatively, the Institute of Medicine (IOM) defines 
vitamin D deficiency as 25(OH)D concentrations less than 20 ng/mL and vitamin D 
sufficiency as greater than 20 ng/mL (Ross et al, 2011).  
Photobiology of Vitamin D 
 
7-DHC and ergosterol, or provitamin D3 and previtamin D3, are the precursors of 
vitamin D.  Both contain conjugated double bonds that absorb ultraviolet (UV) radiation. 
Specifically, UVB radiation with wavelengths between 290-315 nanometers (nm) is 
responsible for the conversion of 7-DHC or ergosterol into previtamin D3 and previtamin 
D2, respectively (Holick, 1985). In humans specifically, 7-DHC is found in the epidermis 
and dermis with the highest concentrations in the stratum basale and spinosum (Holick, 
1985).  
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 UVB radiation is absorbed by the 5,7-diene in 7-DHC and ergosterol, which 
cleaves a carbon-carbon bond between carbons 9 and 10 located in the B ring and 
forming previtamin D (“D” represents both D2 and D3). The difference in the structure of 
ergosterol and 7-DHC and vitamin D2 and vitamin D3 lies in the side chains (Figure 1); 
compared to 7-DHC and vitamin D3, ergosterol and vitamin D2 have a double bond 
between carbons 22 and 23 and a methyl group on carbon 24 (Holick 2003). During 
exposure to sunlight, previtamin D is formed. It also absorbs UV radiation and is 
converted to lumisterol and tachysterol. Thus a photoequilibrium is established. About 
15% of the photoequilibrium is previtamin D. Previtamin D3 converts to tachysterol3, 
lumisterol3, and previtamin D2 is converted to tachysterol2 and lumisterol2. The previtamin 
D3 that converts to vitamin D3 is drawn into the circulation by vitamin D binding protein 
(DBP) in the dermal capillary bed (Holick, 1985).  
 
Figure 1. Structures and photochemistry of vitamin D2, vitamin D3, and vitamin D4. Reprinted with 
permission by Michael Holick, Ph.D., M.D. 
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Metabolism of Vitamin D 
 
Vitamin D2 and vitamin D3 follow the same metabolic pathways (Figure 2). When 
vitamin D is obtained from the diet or supplements, it is incorporated into chylomicrons 
that enter the lymphatic system and drain into the venous system via the superior vena 
cava. Vitamin D3 produced in the skin is bound to DBP and enters the circulation. In the 
liver, it is converted to 25(OH)D, the major circulating form of vitamin D, by several 
liver enzymes including the 25-hydroxylase (CYP2R1). 25(OH)D is measured to 
determine a person’s vitamin D status. In the kidneys, 25(OH)D is further hydroxylated 
to 1,25-dihydroxyvitamin D (1,25(OH)2D) by 25(OH)D-1α-hydroxylase (CYP27B1), 
forming 1α,25-dihydroxyvitamin D, the biologically active form of vitamin D. Whether 
vitamin D is obtained from the sun, diet, or supplements, both 25(OH)D2 and 25(OH)D3 
are equally recognized in the kidney and converted to 1,25(OH)2D2 and 1,25(OH)2D3, 
respectively (2).  
 
Regulation of Vitamin D 
 
The 25(OH)D-1α-hydroxylase (CYP27B1) is tightly regulated by serum 
parathyroid hormone (PTH), calcium, phosphorus, fibroblast growth factor 23 (FGF-23), 
and 1,25(OH)2D (Hossein-nezhad and Holick 2013). Calcium sensors in the parathyroid 
gland detect when serum calcium is low and via signal transduction, increase production 
and release of PTH, in turn increasing 1,25(OH)2D, calcium resorption from bone and 
tubular reabsorption of calcium in the kidney (Figure 2). In addition to low serum 
	  5 
calcium and elevated PTH levels, hypophosphatemia also upregulates CYP27B1, 
increasing the renal production of 1,25(OH)2D. 1,25(OH)2D induces the expression of 
25(OH)D-24-hydroxylase (CYP24). This enzyme breaks down 1,25(OH)2D into its 
biologically inert form of calcitroic acid (Holick 2006). 
 FGF-23 is also a potent regulator of CYP27B1, downregulating its activity. When 
serum phosphorus levels increase, FGF-23 is produced and secreted by the osteocytes in 
bone (Shimada et al, 2004). FGF-23 decreases the activity of 25(OH)D-1α-hydroxylase, 
thereby decreasing concentrations of 1,25(OH)2D. 
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Figure 2. Metabolism and regulation of vitamin D. Reproduced with permission by Michael Holick, Ph.D., 
M.D. 
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Functions of Vitamin D 
 
Vitamin D is critically important for the absorption of dietary calcium and 
phosphorus. Without vitamin D, only 10-15% of dietary calcium and 60% of phosphorus 
is absorbed in the intestine. However, in the presence of vitamin D, intestinal calcium and 
phosphorus absorption is increased to 30-40% and about 80%, respectively (Holick and 
Garabedian 2006).  
In addition to its calcemic effects, vitamin D also has numerous other functions. 
Every cell in the body contains a vitamin D receptor, most notably brain, prostate, breast, 
and colon cells which all respond to 1,25(OH)2D. These cells not only have the vitamin D 
receptor (VDR), but also have a 25(OH)D-1α-hydroxylase to convert 25(OH)D into 
1,25(OH)2D. 1,25(OH)2D is a transcription factor that regulates an estimated 200-2000 
genes, especially those responsible for intestinal calcium absorption, bone calcium 
mobilization, as well as proliferation, differentiation, and apoptosis (Hossein-nezhad and 
Holick 2013).  
Vitamin D also functions as an immunomodulator. Macrophages have the cellular 
machinery to upregulate the VDR and the 25(OH)D-1α-hydroxylase genes, increasing 
concentrations of 1,25(OH)2D. 1,25(OH)2D then interacts with the VDR to enhance the 
production of cathelicidin, a defense protein that destroys any infectious agents (Holick 
2007). Furthermore, it has been shown in microarrays performed on the ribonucleic acid 
(RNA) in the buffy coat that increased 25(OH)D concentrations have a direct effect on 
almost 300 genes (Hossein-nezhad, Spira, and Holick 2013). 
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Vitamin D2 vs. Vitamin D3 
 
There is currently a controversy surrounding the efficacy of maintaining total 
serum 25(OH)D levels after taking supplemental or dietary vitamin D2 versus vitamin D3. 
Some reports have suggested that vitamin D3 was more effective than vitamin D2 at 
maintaining total serum 25(OH)D levels (Trang et al, 1998; Armas et al, 2004; Heaney et 
al, 2011). In contrast, other studies (Holick et al, 2008; Biancuzzo et al, 2010) found that 
the daily ingestion of a 1000 IU vitamin D2 supplement was as effective as the daily 
ingestion of a 1000 IU vitamin D3 supplement at raising and maintaining total serum 
25(OH)D levels. There was no difference in total 25(OH)D levels in healthy adults who 
consumed orange juice that was fortified with 1000 IU of vitamin D2 or 1000 IUs of 
vitamin D3 compared to consuming a supplement containing either 1000 IU vitamin D2 or 
1000 IU vitamin D3 (Biancuzzo et al 2010). It was also found that there was no difference 
in the increase of 25(OH)D3 levels between subjects who consumed vitamin D3-fortified 
orange juice or vitamin D3 supplements or in 25(OH)D2 levels of subjects who consumed 
vitamin D2-fortified orange juice or vitamin D2 supplements (Biancuzzo et al, 2010). 
Additionally, bread fortified with vitamin D3 increased total serum 25(OH)D levels in 
women as effectively as a vitamin D3 supplement (Natri et al, 2006).  
Furthermore, taking 50,000 IU vitamin D2 once a week for 8 weeks and every 
other week thereafter for six years increased serum total 25(OH)D levels and is 
considered to be an effective treatment for vitamin D deficiency (Pietras et al 2009). 
Similarly, it was reported that 50,000 IU vitamin D2 repletion and maintenance therapy in 
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vitamin D deficient patients significantly increased serum 25(OH)D2 and total 25(OH)D 
despite a decrease in serum 25(OH)D3 (Demetriou, Travison, and Holick, 2012).   
 
Bioavailability of Vitamin D2 in Mushrooms 
 
Various foods and beverages have been fortified with vitamin D in the United 
States for more than 80 years since there are few that contain vitamin D naturally. Milk, 
orange juice, bread, other dairy products, and some cereals have been fortified with this 
essential vitamin. Mushrooms exposed to sunlight or ultraviolet radiation are a good 
source of vitamin D2. Several clinical studies have been conducted to determine the 
bioavailability of vitamin D2 and vitamin D3 in fortified foods and beverages and the 
efficacy of fortification in increasing 25(OH)D levels. Fortification of foods with vitamin 
D2 or vitamin D3 has been shown to be a safe and effective way to increase 25(OH)D 
levels in children and adults (Biancuzzo et al, 2010). 
White button mushrooms exposed to UV radiation were found to contain a 
considerable amount of previtamin D2 56.3 µg/100g fresh weight and vitamin D2 at 0.11 
µg/100g fresh weight. After irradiation, white button mushrooms were homogenized and 
analyzed by high performance liquid chromatography (HPLC) to determine the percent 
conversion of previtamin D2 over 96 hours post irradiation. After six hours irradiation, 
24% of previtamin D2 had converted to vitamin D2 in the mushroom and only 10% of 
previtamin D2 had been converted to vitamin D2 in an ampule. Conversion of previtamin 
D2 to vitamin D2 reached a peak of 50% at 11.5 hours. Therefore, mushrooms produce 
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vitamin D2 in their skin similarly to humans making vitamin D3 in the epidermis and are a 
good source of vitamin D2 (Keegan et al, 2013).   
To date, two groups have reported on the bioavailability of vitamin D2 in 
ultraviolet-irradiated mushrooms. A 5 week single-blinded, randomized, placebo-
controlled trial was conducted in 26 healthy Caucasian adults with 25(OH)D levels below 
20 ng/mL. These subjects were randomized to three groups and assigned to receive either 
28,000 IU vitamin D2 from UV irradiated mushrooms in a soup and placebo, 60 IU 
vitamin D2 in soup that contained non-UV-irradiated mushrooms and 28,000 IU vitamin 
D2 in a liquid supplement, or 60 IU vitamin D2 in a non-UV-irradiated mushroom soup 
and placebo supplement four times a week for four weeks.  After four weeks, serum 
25(OH)D levels increased significantly and consuming vitamin D2 from UV-irradiated 
mushrooms was equally as effective at raising 25(OH)D levels as ingesting the same 
amount of vitamin D2 as a supplement (Urbain et al, 2011).  
In a similar study, subjects were randomized to consume one serving of 
mushrooms with a standard meal each day for six weeks. Four groups received either one 
serving of non-UV-irradiated mushrooms plus meal (control), UV irradiated mushrooms 
containing 352 IU vitamin D2 with a meal, UV irradiated mushrooms containing 684 IU 
vitamin D2 with a meal, or a supplement containing 1,128 IU vitamin D2 with non-UV-
irradiated mushrooms. At the end of six weeks, 25(OH)D2 levels were higher in all 
groups except the control group. They observed a significant decrease in serum 
25(OH)D3 in the group receiving 684 IU vitamin D2 in UV irradiated mushrooms and in 
the group receiving the vitamin D2 supplement.  There was a mean decrease of 25(OH)D3 
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of 0.32 ng/mL that was offset by an increase of 0.40 ng/mL in 25(OH)D2. Overall 
however, there was a small decrease in total 25(OH)D levels in the groups consuming 
UV-irradiated mushrooms that contained vitamin D2 (Stephenson et al, 2012).  
Additionally, a case study was published discussing the increase in 25(OH)D 
concentrations of an Indian man living in southeast England (Ozzard et al, 2008). This 
man is a vegetarian, did not consume dairy, and had darker skin. His initial 25(OH)D 
concentration was 17 nanomoles/Liter (nmol/L), which is equivalent to 6.8 ng/mL, 
making him severely deficient. He chose not to take the prescription given to him and 
instead irradiated mushrooms under UV light. He consumed 200 grams of irradiated 
mushrooms daily for 3 months. At the end of this time period, his 25(OH)D 
concentrations had increased to 39 nmol/L, or 15.6 ng/mL. Though he did not become 
vitamin D sufficient (>30 ng/mL), he did raise his 25(OH)D significantly by only 
consuming irradiated mushrooms with no other changes to his diet or sun exposure.  
This clinical study was conducted to determine if ingestion of vitamin D2 in a 
dried white button mushroom extract was as effective at increasing and maintaining 
vitamin D status as supplemental vitamin D3 and vitamin D2. 
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METHODS 
Subjects  
Healthy adults between the ages of 18-68 years were enrolled in February 2012 in 
Boston, Massachusetts. All subjects signed a consent form approved by Boston 
University Institutional Review Board. Those with chronic liver and kidney disease, or 
who were taking more than 2000 IU vitamin D per day, or taking medications such as 
anticonvulsants, glucocorticoids, and barbiturates that could interfere with vitamin D 
metabolism were excluded. Subjects taking a multivitamin were included if the vitamin D 
content was less than 1000 IU. Subjects were given a dietary questionnaire and had a 
blood draw at baseline and every week for twelve weeks. 
 Seventy-five subjects were randomized to take 2000 IU supplemental vitamin D2, 
2000 IU supplemental vitamin D3, 2000 IU mushroom vitamin D2, or a capsule 
containing an equal amount of mushroom powder. The supplemental vitamin D2 was 
manufactured by Nutrapure, Inc. (Park City, UT) and contained cellulose, vegetable 
cellulose capsule, maltodextrin, and magnesium stearate. The supplemental vitamin D3 
was manufactured by Whole Health Products, LLC (Golden, CO) and contained rice 
flour, vegetable capsule (HPMC [cellulose], water, titanium dioxide), and magnesium 
stearate. The mushroom vitamin D2 and mushroom powder were manufactured by 
Monterey Mushrooms, Inc. (Watsonville, CA) and contained dehydrated mushroom 
powder in a gelatin capsule. All supplements were analyzed by Dr. Michael Holick’s 
laboratory. The vitamin D3 capsules and the mushroom vitamin D2 capsules were found 
to contain up to 40% more vitamin D than the label dosage of 2000 IU. The supplemental 
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vitamin D2 had concentrations of vitamin D2 within 20% of 2000 IU. The mushroom 
powder contained no vitamin D.  
Table 1. Vitamin D content in each vitamin D supplement.  
 Nature’s Life 
Vitamin D2 (IU) 
Whole Health 
Vitamin D3 (IU) 
Mushroom 
Vitamin D2 (IU) 
1 2654 2247 3047 
2 2152 2749 2937 
3 2158 2653 2846 
4 2482 2509 3010 
5 2200 2450 2850 
6 2304 2673  
Average ± SD 2325 ± 203 2547 ± 184 2960 ± 91 
 
Analytical Methods 
Calcium, and albumin were measured at baseline and final study visits by Quest 
Diagnostics (Cambridge, MA). 25(OH)D2 and 25(OH)D3 were measured at every visit 
and 1,25(OH)D2 and 1,25(OH)D3 were measured at baseline, middle, and end study visits 
by liquid chromatography mass spectroscopy (LCMS) at Quest Diagnostics Nichols 
Institute, San Juan Capistrano, CA (Holick et al, 2005). The detection limit of the 
25(OH)D assay is 4 ng/mL and the interassay variation coefficient was 10%. PTH was 
measured at baseline and final study visits by the Immunodiagnostics i-SYS system 
(Boldon, United Kingdom).  
The results are reported as mean ± SEM. 
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Statistical Analysis 
 Means, standard deviations, standard errors of the means, and student T 
tests were computed in Microsoft Excel. Baseline and final serum 25(OH)D 
concentrations were analyzed within groups using student T tests. 
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RESULTS 
Seventy five healthy adults were enrolled in the study (25 male, 50 female, mean 
age 29.9 years) and were randomized to ingest capsules containing 2000 IU vitamin D2, 
2000 IU vitamin D3, 2000 IU mushroom vitamin D2, or a capsule containing an 
equivalent amount of mushroom powder once a day for three months during the winters 
of 2012 and 2013 in Boston, Massachusetts. Vitamin D concentrations in the mushroom 
vitamin D2 capsules and vitamin D3 capsules were much higher than what was specified 
on the label (Table 1). Sixty subjects completed the study (39 female, 21 male, mean age 
29.4 years). Twelve subjects were randomized to the supplemental vitamin D2 group, 15 
subjects to the mushroom powder group, 14 subjects to the supplemental vitamin D3 
group, and 19 subjects to the mushroom vitamin D2 group. Serum 25(OH)D was 
measured once a week for 12 weeks by liquid chromatography tandem mass spectroscopy  
(LCMS/MS) as previously described (Holick et al, 2005). 
When including all subjects who finished the study, the supplemental vitamin D2 
group had a mean baseline serum 25(OH)D2 of 1.5 ± 0.8 ng/mL and a mean final serum 
25(OH)D2 of 13.0 ± 1.7 ng/mL. Total serum 25(OH)D levels increased by an average of 
56.4 ± 19.1% with an average baseline total 25(OH)D level of 19.4 ± 2.0 ng/mL and a 
final 25(OH)D level 30.4 ± 2.2 ng/mL. (P<0.001). Subjects in the mushroom powder 
group had a mean baseline serum 25(OH)D3 of 23.2 ± 2.0 ng/mL that significantly 
increased to 26.1 ± 2.1 ng/mL (p < 0.01) with an average increase of 12.4 ± 4.7%. The 
overall total serum 25(OH)D levels significantly increased by an average of 13.3 ± 4.3% 
from 24.0 ± 2.0 ng/mL to 26.7 ± 2.1 ng/mL (p < 0.01). Subjects in the supplemental 
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vitamin D3 group had a mean baseline serum of 25(OH)D3 of 23.1 ± 2.2 ng/mL with a 
final serum 25(OH)D3 of 43.7 ± 3.0 ng/mL. Total 25(OH)D significantly increased by an 
average of 98.5 ± 18.6% from 23.8 ± 2.3 ng/mL to 43.7 ± 3.0 ng/mL (P<0.001). Total 
serum 25(OH)D baseline and final serum concentrations contained detectable 25(OH)D2 
of 0.7 ng/mL and 0.2 ng/mL respectively. Subjects in the mushroom vitamin D2 group 
had a mean baseline serum 25(OH)D2 of 0.8 ±0.3 ng/mL that increased significantly to a 
mean final serum 25(OH)D2 of 18.7 ± 1.7 ng/mL (p < 0.001). Total serum 25(OH)D 
levels increased by an average of 45.5 ± 17.6%. Total 25(OH)D serum levels increased 
from an average baseline of 22.3 ±2.0 ng/mL to an average final of 32.5 ± 2.4 ng/mL and 
was statistically significant (p<0.001). 
Baseline serum total 25(OH)D levels were not significantly different between the 
groups 19.4 ± 2.0 ng/mL, 24.0 ± 2.0 ng/mL, 23.8 ± 2.3  ng/mL, and 22.2 ± 2.0 ng/mL for 
the supplemental vitamin D2, mushroom powder, supplemental vitamin D3, and 
mushroom vitamin D2 groups respectively. Serum 25(OH)D levels gradually increased 
and plateaued at 7 weeks and were maintained for the following 5 weeks. At the end of 
12 weeks, final serum total 25(OH)D levels were statistically significantly different 
between supplemental vitamin D2 and supplemental vitamin D3 (p < 0.001), between 
mushroom powder and supplemental vitamin D3 groups (p < 0.001), and between 
supplemental vitamin D3 and mushroom vitamin D2 groups (p < 0.01). In the groups 
taking mushroom powder and mushroom vitamin D2, a student’s t-test revealed a p-value 
of <0.01, indicating that the change in 25(OH)D concentrations between those groups 
was significantly different.  
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However, a subject randomized to take supplemental vitamin D2 and a subject 
randomized to take mushroom powder were presumed to be noncompliant upon further 
evaluation of the change in 25(OH)D concentrations from baseline to final visits. The 
subject in the supplemental vitamin D2 group had increasing 25(OH)D2 concentrations for 
the first 7 weeks and then 25(OH)D2 declined to a barely detectable level by week 12, 
implying that the supplement had not been taken for the remainder of the study. A subject 
in the placebo mushroom powder group enrolled in late spring of 2013 and total 
25(OH)D concentrations increased over the course of 12 weeks from 24.5 ng/mL to 35.2 
ng/mL, most was 25(OH)D3 presumably because of sun exposure producing vitamin D3 
in the skin. Removing these subjects from the data result in minor changes that were 
insignificant to the mean 25(OH)D concentrations. A comparison of the values is shown 
in Table 3. 
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Table 2. Changes in 25(OH)D concentrations and significant differences after removal of noncompliant 
subjects. §Denotes mean 25(OH)D values after removing noncompliant subjects. (*p = 0.01, **p = 0.001, 
***p = <0.001) 
 After these subjects were removed, the samples sizes for each group were: 11 in 
the supplemental vitamin D2 group, 14 in the placebo mushroom powder group, 14 in the 
supplemental vitamin D3 group, and 19 in the mushroom vitamin D2 group. The baseline 
and final serum concentrations of 25(OH)D were statistically significantly different 
within all groups (Figure 3).  
These adjusted results demonstrate ingestion of mushrooms containing D2 or 
taking supplemental vitamin D2 caused a statistically significant increase in 25(OH)D 
concentrations compared to mushroom powder, but mushroom vitamin D2 was not as  
effective in increasing and maintaining total serum 25(OH)D levels as supplemental 
vitamin D3. 
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Figure 3. Mean (±SEM) total 25-hydroxyvitamin D (♦), 25-hydroxyvitamin D3 (!), and 25-
hydroxyvitamin D2 (!) concentrations over time after removal of presumed noncompliant subjects after 
oral administration of  (A) 2000 IU of supplemental vitamin D2 in capsules (n = 11), (B) oral administration 
of mushroom powder in capsules (n = 14), (C) oral administration of 2000 IU supplemental vitamin D3 in 
capsules (n = 14), and (D) oral administration of 2000 IU mushroom vitamin D3 in capsules (n = 19). 
Serum 25(OH)D concentrations are statistically significantly different from baseline to end of the study 
(*** p < 0.001, ** p < 0.01, * p < 0.05). 
 
In the supplemental vitamin D2 group, 1,25(OH)2D3 significantly decreased from 
54.0 ± 4.0 to 36.4 ± 4.1 pg/mL and 1,25(OH)2D2 significantly increased from 1.3 ± 1.3 to 
13.0 ± 3.5 pg/mL. Total 1,25(OH)2D was not statistically significantly different from 
baseline to end of the study. In the mushroom powder group, serum concentrations of 
1,25(OH)2D3 did not change from baseline to end from 48.7 ± 3.7 to 49.5 ± 4.1 pg/mL; 
the concentration of 1,25(OH)2D2 in the group that received the placebo mushroom 
powder did not change. Total serum 1,25(OH)2D concentrations in this group did not 
change from 49.4 ± 3.7 to 49.5 ± 4.1 pg/mL. In the supplemental vitamin D3 group, 
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serum concentrations of total 1,25(OH)2D, 1,25(OH)2D2, and 1,25(OH)2D3 did not 
significantly change. Concentrations of 1,25(OH)2D2 in the mushroom vitamin D2 group 
significantly increased from 0.4 ± 0.4 to 22.4 ± 2.5 pg/mL (p < 0.01) with a 
corresponding significant decrease in 1,25(OH)2D3 from 46.6 ± 3.4 to 26.0 ± 2.2 pg/mL 
(p < 0.01). Total 1,25(OH)2D concentrations did not change from 47.1 ± 3.4 to 48.4 ± 2.7 
pg/mL (p = 0.4). These results indicate that 1,25(OH)2D concentrations are tightly 
regulated regardless of the source of vitamin D (Figure 4).  
 
 
 
 
 
 
 
 
 
 
Figure 4. Mean (±SEM) total 1,25-dihydroxyvitamin D (♦),1,25-dihydroxyvitamin D3 (!), and 1,25-
dihydroxyvitamin D2 (!) concentrations over time after oral administration of (A) 2000 IU of supplemental 
vitamin D2 in capsules (n = 11), (B) mushroom powder in capsules (n = 14), (C) 2000 IU supplemental 
vitamin D3 in capsules (n = 15), or 2000 IU mushroom vitamin D3 in capsules (n = 19). 
 
Serum calcium, albumin, and PTH did not change from baseline to the end of the 
study. Results are summarized in Table 3. 
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Table 3. Serum PTH, calcium, and albumin reported as mean ± SEM. 
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DISCUSSION 
 The study shows that the total achieved 25(OH)D concentrations were statistically 
significantly different between the groups taking 2000 IU supplemental vitamin D2, 2000 
IU supplemental vitamin D3, and 2000 IU mushroom vitamin D2 compared to the placebo 
group. Hence, it can be concluded that the mushrooms exposed to UVB and ingested 
provide vitamin D2 that is bioavailable and effective in raising and maintaining serum 
25(OH)D concentrations as the other commercially available vitamin D supplements. 
 The change in total 25(OH)D concentrations after 12 weeks were 11.8 ng/mL ± 
2.2 ng/mL, 2.1 ± 0.8 ng/mL, 20.2 ± 2.6 ng/mL, and 10.2 ± 2.1 ng/mL in the supplemental 
vitamin D2 group, mushroom powder group, supplemental vitamin D3 group, and the 
mushroom vitamin D2 group, respectively. There were significant differences in the 
change in final serum total 25(OH)D concentrations between the groups taking 
supplemental vitamin D2 and supplemental vitamin D3, mushroom powder and 
supplemental vitamin D3, and supplemental vitamin D3 and mushroom vitamin D2. 
 We did observe a significant decrease in 25(OH)D3 in the group taking mushroom 
vitamin D2 and a nonsignificant decrease in 25(OH)D3 in the group taking supplemental 
vitamin D2 which is likely due to the increased amount of vitamin D2 in the circulation 
and subsequent hydroxylation in the liver to 25(OH)D2. Total 25(OH)D concentrations in 
the group taking the placebo mushroom powder increased by 13.3 ± 4.3% from baseline 
to the end of the study that was not statistically significant. However, after removing one 
presumed noncompliant subject from the mushroom placebo group (subjects were asked 
to refrain from direct sun exposure without sun protection) and one from the 
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supplemental vitamin D2 group who appeared to have stopped taking the supplement 
halfway through the study, there was no significant difference in the change in serum 
total 25(OH)D concentrations between the groups taking mushroom vitamin D2 and 
supplemental vitamin D2. There was however, a significant difference in the change in 
25(OH)D concentrations between the groups taking mushroom vitamin D2 and 
supplemental vitamin D3 and between the groups taking supplemental vitamin D2 and 
supplemental vitamin D3.  
  In regards to total serum 1,25(OH)2D concentrations, Biancuzzo et al 
conducted a similar study supplementing 1000 IU vitamin D2 or 1000 IU vitamin D3 for 
11 weeks and observing concentrations of 1,25(OH)2D. Serum total 25(OH)D 
concentrations did not differ between the groups. In the group taking 1000 IU vitamin D3, 
total 1,25(OH)2D and 1,25(OH)2D3 did not change. However, the group taking 1000 IU 
vitamin D2 had increasing levels of 1,25(OH)2D2 that plateaued at six weeks and a small 
decrease in 1,25(OH)2D3 that was not statistically significant. The data seemed to suggest 
an upward trend in total 1,25(OH)2D in the group taking vitamin D2, however, the 
baseline and final serum concentrations for total 1,25(OH)2D were not statistically 
significantly different. This study confirmed that total 1,25(OH)2D concentrations do not 
increase despite ingesting vitamin D2 or vitamin D3 and increasing intake by 1000 IU. 
Total 1,25(OH)2D in each of the groups taking vitamin D2 did not change from baseline 
to end of the study (Biancuzzo et al, 2013). In the current study, concentrations of 
1,25(OH)2D remained unchanged regardless of the source and type of vitamin D, 
confirming that total 1,25(OH)2D concentrations are tightly regulated. The results also 
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demonstrate not only that vitamin D2 was as effective as vitamin D3 in maintaining levels 
of 25(OH)D and 1,25(OH)2D, but also that vitamin D2 from mushrooms was as effective 
as supplemental vitamin D2 and vitamin D3.  
 In conclusion, vitamin D2 from mushrooms was effective at raising and 
maintaining 25(OH)D concentrations and maintaining total 1,25(OH)2D concentrations. 
In those taking vitamin D2, it is clear that the kidney recognizes and converts vitamin D2 
and vitamin D3 to 25(OH)D2 and 25(OH)D3 respectively. Thus vitamin D2 is as effective 
as vitamin D3 in increasing and maintaining vitamin D status. Furthermore, vitamin D2 
from UVB irradiated mushrooms is as bioavailable as supplemental vitamin D2 and 
supplemental vitamin D3 and is a novel, economical, and accessible source of vitamin D. 
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